If this box remains here for more than 30 seconds, click this link to try again.
Industries
Functions
Home » Products & Services » Benchmarking Reports » Patient Focused Services » Patient Support Programs
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Download FREE Excerpt
Industries Profiled: Health Care; Pharmaceutical; Diagnostic; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Medical Device; Consumer Products Companies Profiled: Abbott; UCB Pharma; Sanofi; Novo Nordisk Novartis; Mylan; Merck; Medtronic; Lilly; Gilead Sciences; Helsinn; Boston Scientific; Boehringer Ingelheim; Biogen Idec; Baxter BioScience; Bayer Healthcare; AstraZeneca; Apotex; Abbvie
Study Snapshot Twenty-two marketing and patient engagement leaders from 19 different companies participated in this study. This report presents findings for all companies and for Large Company and Diabetes segments.
Key Findings Many forces of market change: The Affordable Care Act and other market changes are challenging pharmaceutical marketers. Power and influence are shifting among market constituents. Patient-focus Critical in Crowded Markets: In crowded markets, many factors in addition to efficacy and safety influence patient preferences and choices. Patient-focused programs and support are forms of differentiation.